These news releases are hilarious! These paragraphs are ooozing with bullshit.
My fav line is the one where they say "and a big data-driven clinical research and development algorithm in order to bring relief to patients in communities across the country."
If this statement is not the most full of bull, I don't know what is. I like how they say "a big"!!!! How can anyone take them seriously when they say a research and development algorithm is going to bring relief to patients across the country. Too much!!
Read on for a good laugh!
Other good phrases:
"Lock in industry standards"
"consumer health and beauty products"
"GB Sciences’ cultivation methodology ensures a consistent ratio of the plant’s medicinal properties for each and every harvest. This is a critical factor when creating formulations for standardized therapeutic products". WOW!! Lol
GBLX – Cultivating Turnkey Solutions for the Medical Cannabis Industry
GrowBLOX Sciences (“GB Sciences”) is a nature-inspired company employing a novel approach toward cannabis-based medicine. The company is focused on offering a turnkey business solution: transforming cannabis into safe and consistent medicine.
GB Sciences’ focus is on the research of indoor agriculture technology for the medical cannabis industry. The company merges state-of-the-art technologies in plant biology, cultivation and post-production processes in order to optimize safe, consistent medical cannabis. In doing so, the company is also pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm in order to bring relief to patients in communities across the country.
As part of its efforts to lock in industry standards, GB Sciences is developing a comprehensive line of highly effective cannabis-based therapies ranging from custom medical compounds to consumer health and beauty products. GB Sciences’ cultivation methodology ensures a consistent ratio of the plant’s medicinal properties for each and every harvest. This is a critical factor when creating formulations for standardized therapeutic products.
GB Sciences’ drug development program also endeavors to unlock the path to drug discovery and to provide novel cannabinoid therapies to patients with critically unmet needs. The company is developing the GrowBLOX system, a proprietary technology that allows for controlled growing conditions for the manufacture of toxin-free, natural, and medicinal-grade cannabis and cannabis concentrates. Starting with certified, cannabis plant-derived ingredients from the GrowBLOX technology suite, GB Sciences tests proprietary ratios of active ingredients in an accelerated drug development program. It also focuses on the research, testing and development of FDA-approved medical treatments and nutraceuticals using extracts from the cannabis sativa plant.
GrowBLOX Sciences is gearing up to cultivate the medical cannabis industry in new ways. The company’s science and research efforts power discovery, its engineering and design activities bring ideas into the real world, and its big data methodology drives continuous improvement.
